Sat.Jan 14, 2023 - Fri.Jan 20, 2023

article thumbnail

AI continues to gain momentum in the biopharmaceutical industry in 2023

Pharmaceutical Technology

While the biopharmaceutical industry has been impacted and pressured by various factors such as the Covid-19 pandemic, inflation, the Ukraine-Russia war, ongoing supply chain issues, and a challenging economic environment, collaboration between pharma companies and emerging technologies providers continues to grow, especially in the research and development (R&D) field, offering some resilience in times of geopolitical and economic disruptions.

article thumbnail

Three-Dose Hepatitis B Vaccine Regimen Can Protect Those With HIV

Drug Topics

Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WTAS: Inflation Reduction Act already impacting R&D decisions

PhRMA

The Inflation Reduction Act’s (IRA’s) drug price setting provisions, as predicted, are already impacting biopharmaceutical research & development (R&D) decisions. Whether you are looking at estimates of how many fewer medicines or indications will be developed, or noting shifts away from areas of unmet patient need because the law is signaling those innovations are not valued, the IRA’s price setting provisions are a loss for patients everywhere.

article thumbnail

FDA’s 2022 drug approvals fall short of recent norms

PharmaVoice

The U.S. agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

HSV Offers Promising Target for Preventive, Therapeutic Vaccines

Pharmacy Times

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

article thumbnail

Antipsychotic Prescriptions on the Rise Among Pediatric Patients

Drug Topics

A recent study found a rise in the prevalence of antipsychotic prescriptions among pediatric patients and noted which antipsychotics were most commonly used for specific indications.

More Trending

article thumbnail

The M&A hunt is on — here are the prime targets

PharmaVoice

Companies with advanced molecular therapies, oncology assets and obesity treatments could be fuel for a dealmaking fire this year.

article thumbnail

FDA Approved IND for CAR T Cell That Target Metastases-Causing Breast Cancer Tumor

Pharmacy Times

The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.

FDA
article thumbnail

Tdap Vaccine Approved by FDA for Use During Pregnancy for Pertussis Prevention

Drug Topics

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

article thumbnail

HIV vaccine being developed by Johnson & Johnson fails clinical trial

STAT

Yet another experimental HIV vaccine has failed. The National Institute of Allergy and Infectious Diseases reported Wednesday that a Phase 3 clinical trial of a vaccine was stopped because the vaccine was ineffective at preventing HIV infection. The vaccine was being developed by Janssen, the vaccine division of Johnson & Johnson.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pro sports’ COVID protocols led to real-world data impacts for pharma

PharmaVoice

After years of pioneering new methods for using data and technology to improve patient health outcomes, IQVIA’s Christina Mack is on the cusp of a research revolution.

article thumbnail

Study: Empagliflozin Can Slow Progression of Chronic Kidney Disease to Kidney Failure

Pharmacy Times

Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.

article thumbnail

Rising Prices for Insulin Cause for California's Lawsuit Against Drug Makers, PBMs

Drug Topics

Pharmaceutical makers, price managers out of control with ‘necessary drug’ for millions, Attorney General says.

article thumbnail

Mix-it-yourself Wegovy? Some are trying risky sources for weight-loss drugs

STAT

With a few clicks, Daniel added the chemical to his online cart and ordered it. In less than a week, a vial containing white powder arrived at his house. He used a syringe to measure out sterile water and eject it into the vial to dissolve the powder. Then, with a different syringe, he drew up about a quarter of a milliliter of the solution and injected it into his lower abdomen.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution. Whether it’s soaring temperatures, extreme cold snaps, or devastating floods, pharmaceutical logistics providers must ensure that shipments reach their destination in their intended condition without defect or delay.

article thumbnail

Fourteen Percent of Those Who Contracted COVID-19 Face Long-Term Challenges

Pharmacy Times

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

article thumbnail

FDA Grants Priority Review Designation to OPNT003 Nasal Nalmefene for Opioid Overdose

Drug Topics

The PDUFA date has been set for May 22, 2023.

FDA
article thumbnail

A new study links social media use to changes in teen brains. Is that a bad thing?

STAT

Today’s teens and tweens have never known a world without social media. There are still a lot of open questions about how sites like TikTok and Instagram may shape their development — and stories focusing on the potential negative impacts of social media tend to dominate the news. But a recent study published in JAMA Pediatrics is the latest in a growing body of research that suggests the relationship that young people have with social media is too complicated to be categorized as

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare

Fierce Healthcare

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25

article thumbnail

ADHD Traits Linked to Anxiety, Depression More Than Autistic Traits

Pharmacy Times

There is a lack of funding for attention-deficit hyperactivity disorder and coinciding psychological research compared to the funds generated for autism research.

article thumbnail

Urgent Need to Increase Vaccinations in Children

Drug Topics

Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.

article thumbnail

JPM23: Pfizer, Moderna and more look to combine COVID and flu vaccine markets

Fierce Pharma

JPM23: Pfizer, Moderna and more look to combine COVID and flu vaccine markets zbecker Fri, 01/20/2023 - 14:48

article thumbnail

Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds

Fierce Healthcare

Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds aburky Wed, 01/18/2023 - 16:40

article thumbnail

Highlights From SABCS 2022 Clinical Trial Data

Pharmacy Times

Significant study results may help inform clinical practice strategies.

article thumbnail

Extended-Release Risperidone Approved by FDA for Schizophrenia

Drug Topics

Rykindo is a bi-weekly long-acting risperidone injection to treat patients with schizophrenia and bipolar 1 in adults.

FDA
article thumbnail

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices

Fierce Pharma

CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49.

article thumbnail

UnitedHealthcare launches behavioral health coaching program for commercial plans

Fierce Healthcare

UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05

article thumbnail

Barriers to Optimal Care for Patients Diagnosed with MDS

Pharmacy Times

Dr Mancini navigates challenges inhibiting patients to receive optimal care amid diagnosis of MDS.

article thumbnail

Positive Topline Results Announced from Pivotal Efficacy Trial of mRNA Vaccine for RSV

Drug Topics

Moderna’s mRNA-1345 vaccine targets RSV in older adults.

article thumbnail

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out

Fierce Pharma

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out. aliu. Wed, 01/18/2023 - 14:00.

article thumbnail

New Jefferson Health program enables clinical, academic nurses to partner on research

Fierce Healthcare

New Jefferson Health program enables clinical, academic nurses to partner on research agliadkovskaya Wed, 01/18/2023 - 14:16

article thumbnail

Pharmacists Play Key Role in Encouraging COVID-19 Booster Uptake

Pharmacy Times

Educating patients, posting on social media, and countering misinformation are critical strategies.

article thumbnail

Obeticholic Acid NDA Accepted by FDA

Drug Topics

There are no currently approved medications for the treatment of NASH.

FDA